Elisa Agostinetto shared a post on LinkedIn:
”Triple negative breast cancer: not so negative anymore!
At ESMO24 I discussed with Peter Schmid the results one of the most awaited LBA: the overall survival data of KEYNOTE-522. We discuss here the practice changing implications and tips for clinical practice.”
Read further.
Source: Elisa Agostinetto/LinkedIn
Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute. Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.